Overview

Effect of Administration of 3rd Generation Cephalosporin on the Digestive Carrying of 3rd Generation Cephalosporin-resistant Enterobacteriaceae (CEF-IMPACT)

Status:
Unknown status

Trial end date:
2020-10-01

Target enrollment:

Participant gender:

Summary

The aim of this study was to compare the frequency of occurrence of digestive carrying of 3rd generation cephalosporin-resistant enterobacteriaceae (EB C3G-R), acquired during hospitalization in one of the participating departments, between patients treated with ceftriaxone and patients treated with cefotaxime

Phase:

Phase 4

Details

Lead Sponsor:

Centre Hospitalier Universitaire de Besancon

Treatments:

Cefotaxime
Cefoxitin
Ceftriaxone
Cephalosporins